Association of the DAT1 polymorphism with attention deficit hyperactivity disorder (ADHD): A family‐based approach

The dopamine transporter gene (DAT1) is of particular interest in the genetic study of attention deficit hyperactivity disorder (ADHD), because psychostimulants interact directly with the dopamine transporter protein. Association between ADHD and the 10‐repeat allele of a 40 base pair (bp) variable number of tandem repeats (VNTR) polymorphism of DAT1 was first reported in 1995 [Cook et al. (1995); Am J Hum Genet 56:993–998]. Subsequently, several investigators have also confirmed this association, although others reported conflicting results. We analyzed the DAT1 polymorphism in a sample of 33 Korean probands with a Diagnostic and Statistical Manual of Mental Disorders version IV (DSM‐IV) diagnosis of ADHD and found evidence of increased transmission of the 10‐repeat allele using transmission disequilibrium test (TDT) (P = 0.001; OR = 7.88, CI = 2.20–28.29). These data support the role of DAT1 in ADHD susceptibility among Asian populations. © 2006 Wiley‐Liss, Inc.

[1]  M. Gill,et al.  Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.

[2]  S. Nelson,et al.  No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. , 1999, Psychiatric genetics.

[3]  J. Mill,et al.  Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples , 2001, Molecular Psychiatry.

[4]  M. Nöthen,et al.  Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder , 2001, Biological Psychiatry.

[5]  Keun-Ah Cheon,et al.  The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate , 2005, European Neuropsychopharmacology.

[6]  A. Pickles,et al.  Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the Virginia Twin Study of Adolescent Behavioral Development. , 1997, Journal of child psychology and psychiatry, and allied disciplines.

[7]  Conners Ck,et al.  Rating scales and checklists for child psychopharmacology. , 1985 .

[8]  R. Barkley,et al.  Rating scales and checklists for child psychopharmacology. , 1985, Psychopharmacology bulletin.

[9]  J. Terwilliger,et al.  A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. , 1992, Human heredity.

[10]  Michael Fitzgerald,et al.  Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[12]  D. Blakely,et al.  Population genetic study of the human dopamine transporter gene (DAT1) , 1995, Genetic epidemiology.

[13]  M. Owen,et al.  A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder , 2000, Molecular Psychiatry.

[14]  L. Rohde,et al.  Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. , 2001, American journal of medical genetics.

[15]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[16]  Yufeng Wang,et al.  Family‐based and case‐control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  L M Greenberg,et al.  Developmental normative data on the test of variables of attention (T.O.V.A.). , 1993, Journal of child psychology and psychiatry, and allied disciplines.

[18]  M. Gill,et al.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.

[19]  X Li,et al.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.

[20]  C. Edelbrock,et al.  Manual for the Child: Behavior Checklist and Revised Child Behavior Profile , 1983 .

[21]  Sung-Zoon Cho,et al.  A STUDY OF THE DEVELOPMENT AND STANDARDIZATION OF ADHD DIAGNOSTIC SYSTEM , 2000 .

[22]  J. Rainer.  Genes and the mind, Ming T. Tsuang and Randall Vandermey. Oxford, Oxford University Press, 1980, 143 pages, $12.95 , 1981 .

[23]  J. Swanson,et al.  Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach , 1998, Molecular Psychiatry.

[24]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[25]  I. Waldman,et al.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. , 1998, American journal of human genetics.

[26]  J L Rapoport,et al.  Treatment of attention-deficit-hyperactivity disorder. , 1999, The New England journal of medicine.

[27]  T. Achenbach.  Manual for the child behavior checklist/4-18 and 1991 profile , 1991 .

[28]  D. Curtis,et al.  An extended transmission/disequilibrium test (TDT) for multi‐allele marker loci , 1995, Annals of human genetics.

[29]  S. Purcell,et al.  The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample , 2003, Molecular Psychiatry.